Complete Story
10/02/2020
Janssen announces unbranded national broadcase
Janssen announces the commencement of the "Recent Guidelines and Guidance Incorporating Long-Acting Injectables as a Treatment Option for Adult Patients With Schizophrenia" unbranded national broadcast, which will kick off on Oct. 8 at 12:00 PM, 3:00 PM, and 7:00 PM ET.
Hear from Dr. Joe Parks of the National Council for Behavioral Health and Dr. Rebecca Roma, adjunctive faculty member at the University of Pittsburgh School of Medicine and Psychiatrist at Mercy Behavioral Health in Pittsburgh, as they discuss the impact of repeated relapse on adult patients with schizophrenia, review the recently updated treatment guidelines supporting long-acting injectables, and discuss how to shift the current treatment paradigms.
The panel will be moderated by Dr. Henry Nasrallah, Director of Schizophrenia and Neuropsychiatry Programs at the University of Cincinnati College of Medicine.
